ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 33 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $287,000 | -35.5% | 678,489 | -0.5% | 0.00% | – |
| Q4 2016 | $445,000 | -80.0% | 681,886 | -3.3% | 0.00% | – |
| Q3 2016 | $2,222,000 | -9.3% | 704,814 | -11.1% | 0.00% | – |
| Q2 2016 | $2,449,000 | +21.6% | 792,859 | +42.5% | 0.00% | – |
| Q1 2016 | $2,014,000 | -16.9% | 556,307 | +6.6% | 0.00% | – |
| Q4 2015 | $2,423,000 | -22.9% | 522,082 | +1.2% | 0.00% | – |
| Q3 2015 | $3,142,000 | +8.3% | 516,139 | +53.4% | 0.00% | – |
| Q2 2015 | $2,901,000 | +36162.5% | 336,470 | +2549.4% | 0.00% | – |
| Q4 2013 | $8,000 | -52.9% | 12,700 | -66.7% | 0.00% | – |
| Q2 2013 | $17,000 | – | 38,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |